USPTO serial 76038881
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
2100 COPENHAGEN, DK
2950 Vedbaek, DK
2100 COPENHAGEN, DK
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Clarke Weber
CYNTHIA CLARKE WEBER SUGHRUE, MION, ZINN, MACPEAK & SEAS2100 PENNSYLVANIA AVE N WWASHINGTON, DC 20037UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | CHEMICALS USED IN THE MANUFACTURE OF RESEARCH TOOLS, DRUG DISCOVERY TOOLS, DRUGS CANDIDATES AND DRUGS FOR USE IN THE PHARMACEUTICAL, BIOTECHNOLOGICAL, AND VETERINARY INDUSTRY AND SCIENCE; CHEMICAL REAGENTS FOR SCIENTIFIC AND RESEARCH USE; CHEMICAL SUBSTANCES FOR LABORATORY ANALYSIS USE IN RESEARCH AND DEVELOPMENT; CHEMICALS FOR USE AS A RESEARCH TOOL FOR SCIENTIFIC AND RESEARCH USE, NONE OF THE FOREGOING GOODS BEING GASTROINTESTINAL PREPARATIONS NOT INCLUDING GASTROINTESTINAL PREPARATIONS | ACTIVE | — |
| 005 | PHARMACEUTICAL AND VETERINARY PREPARATIONS, NAMELY FOR THE TREATMENT OF CANCER, INFLAMMATORY DISEASES, IMMUNOLOGY DISEASES, INFECTIOUS DISEASES, DIABETES, HYPERTENSION AND DEPRESSION, MUSCOSKELETAL DISEASES, CARDIOLOGICAL AND VASCULAR DISEASES AND DISORDERS, PULMONARY AND RESPIRATORY DISEASES, ENDOCRINE DISEASES AND DISORDERS, HEMATOLOGICAL DISEASES, NEPHROLOGICAL AND UROLOGICAL DISEASES, NEUROLOGICAL DISEASES, OPHTHALMOLOGICAL DISEASES, OTOLARYNGOLOGICAL DISEASES, RHEUMATOLOGICAL DISEASES AND DISEASES AND CONDITIONS RELATED TO TRAUMA AND EMERGENCY; CHEMICO-PHARMACEUTICAL PREPARATIONS FOR PHARMACEUTICAL, MEDICAL, VETERINARY AND THERAPEUTIC PURPOSES, NAMELY FOR TREATING CANCER, INFLAMMATORY DISEASES, IMMUNOLOGY DISEASES, INFECTIOUS DISEASES, DIABETES, HYPERTENSION AND DEPRESSION, MUSCOSKELETAL DISEASES, CARDIOLOGICAL AND VASCULAR DISEASES AND DISORDERS, PULMONARY AND RESPIRATORY DISEASES, ENDOCRINE DISEASES AND DISORDERS, GASTROENTEROLOGICAL DISEASES, HEMATOLOGICAL DISEASES, NEPHROLOGICAL AND UROLOGICAL DISEASES, NEUROLOGICAL DISEASES, OPHTHALMOLOGICAL DISEASES, OTOLARYNGOLOGICAL DISEASES, RHEUMATOLOGICAL DISEASES AND DISEASES AND CONDITIONS RELATED TO TRAUMA AND EMERGENCY; CHEMICAL REAGENTS FOR CLINICAL MEDICAL, VETERINARY AND THERAPEUTIC PURPOSES; PHARMACEUTICAL PREPARATIONS, NAMELY DRUGS AND DRUG CANDIDATES FOR MEDICAL, VETERINARY AND THERAPEUTIC PURPOSES FOR TREATING CANCER, INFLAMMATORY DISEASES, IMMUNOLOGY DISEASES, INFECTIOUS DISEASES, DIABETES, HYPERTENSION AND DEPRESSION, MUSCOSKELETAL DISEASES, CARDIOLOGICAL AND VASCULAR DISEASES AND DISORDERS, PULMONARY AND RESPIRATORY DISEASES, ENDOCRINE DISEASES AND DISORDERS, HEMATOLOGICAL DISEASES, NEPHROLOGICAL AND UROLOGICAL DISEASES, NEUROLOGICAL DISEASES, OPHTHALMOLOGICAL DISEASES, OTOLARYNGOLOGICAL DISEASES, RHEUMATOLOGICAL DISEASES AND DISEASES AND CONDITIONS RELATED TO TRAUMA AND EMERGENCY; NON OF THE FOREGOING GOODS BEING FOR GASTROINTESTINAL PREPARATIONS | ACTIVE | — |
| 042 | RESEARCH AND DEVELOPMENT IN THE FIELD OF DRUG DISCOVERY, DRUG DEVELOPMENT, TARGET VALIDATION AND SCIENCE; PROFESSIONAL CONSULTANCY IN THE FIELD OF CHEMICAL ANALYSIS AND RESEARCH, BIOLOGICAL ANALYSIS AND RESEARCH, BIOCHEMICAL ANALYSIS AND RESEARCH, BIOLOGICAL ANALYSIS AND RESEARCH AND MOLECULAR BIOLOGY ANALYSIS AND RESEARCH; PATENT EXPLOITATION, NAMELY LICENSING OF CHEMICAL ANALYSIS, PROCESSES, MEDICAL, DIAGNOSTIC AND THERAPEUTIC TREATMENT PATENTS, CHEMICAL ANALYSIS AND RESEARCH; ANALYSIS OF THERAPEUTICAL EFFECTS OF CHEMICAL, PHARMACEUTICAL, MEDICAL AND VETERINARY PREPARATION; TARGET VALIDATION SERVICES AND CONSULTING; NONE OF THE FOREGOING SERVICES BEING IN THE FIELD OF GASTROINTESTINAL PREPARATIONS | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 26, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 26, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 12, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 18, 2004 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jul 28, 2004 | FAXX | FAX RECEIVED | — |
| Dec 4, 2002 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 22, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 22, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 19, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 24, 2001 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 23, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 23, 2000 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2000 | DOCK | ASSIGNED TO EXAMINER | — |